Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
PediaCare Decongestant and Cough Infant Drops
- Development stage
- Unknown
- Lead developer
- Prestige Consumer Healthcare
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
PediaCare Decongestant and Cough Infant Drops is an over-the-counter combination medication designed for pediatric use to alleviate symptoms of the common cold and respiratory infections. It contains two primary active ingredients: dextromethorphan hydrobromide, a cough suppressant that acts on the cough center in the medulla to elevate the cough threshold, and phenylephrine hydrochloride, a sympathomimetic amine that acts as a selective alpha-1 adrenergic receptor agonist to reduce nasal congestion by constricting blood vessels in the nasal mucosa. The product is formulated as oral drops and is typically flavored and free of alcohol and dyes. While historically marketed for infants, current clinical guidelines from the FDA and pediatric organizations generally advise against the use of OTC cough and cold medicines in children under 4 years of age due to safety concerns and lack of proven efficacy in this age group.
- Brand names
- PediaCare Decongestant and Cough Infant Drops
02
Targets
ADRA1A (α1A)SIGMAR1 (Sigma non-opioid intracellular receptor 1)NMDAR (Glutamate receptor ionotropic, NMDA)
Beyond the preview
Go deeper on PediaCare Decongestant and Cough Infant Drops.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PediaCare Decongestant and Cough Infant Drops.